Barbara Duncan
Board Member
Halozyme Therapeutics, Inc. (HALO)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Barbara Duncan
Barbara Duncan is recorded as Board Member at Halozyme Therapeutics, Inc. (HALO). Halozyme Therapeutics, Inc. reported in an 8-K filed February 6, 2023 that Barbara Duncan was appointed Board of Directors, effective February 3, 2023.
“On February 3, 2023, Barbara Duncan was elected to the Board of Directors of Halozyme Therapeutics, Inc. (the “Company”).”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-02-03–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Halozyme Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Helen Torley CEO, Board Member
- Darren Snellgrove CFO
- Elaine D. Sun CFO
- Nicole LaBrosse CFO
- Cortney Caudill COO
- Mark Snyder General Counsel
- Bernadette Connaughton Board Member
- Connie L. Matsui Board Member
- Dannielle Appelhans Board Member
- James Lang Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.